Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo

Update Il y a 4 ans
Reference: NCT00332280

Woman and Man

Extract

The purpose of the study is to evaluate the efficacy and the safety of AMT2003 in cancer patients with advanced disease. The primary evaluation criterion is clinical benefit response.


Inclusion criteria

  • gastrointestinal cancer ,Prostate cancer ,Genital Neoplasms, Female

Links